Figure 2.

The cumulative incidence function with death as a competing risk for time from eligibility of therapy to HAART initiation stratified by gender.

Thorsteinsson et al. BMC Infectious Diseases 2012 12:293   doi:10.1186/1471-2334-12-293
Download authors' original image